BioNTech SE
PublicBioNTech SE is now publicly traded
The data on this page reflects BioNTech SE's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Oct 10, 2019
Last Round
Grant
May 20, 2025
Total Funding Raised
$1.87B
Company Overview
BioNTech SE is a biotechnology company that develops and commercializes immunotherapies for cancer and other infectious diseases.
Sector
Healthcare
AI Layer
Application
Keywords
mRNA vaccine platformmRNA cancer immunotherapiesCOVID-19 mRNA vaccineindividualized cancer immunotherapycancer and infectious disease immunotherapypharmaceutical co-development partnership modelengineered cell therapyCAR-T cell therapy developmentantibody-drug conjugates (ADCs)drug commercialization profit-sharinggovernment vaccine supply contractssmall molecule immunomodulators
BioNTech SE Comparables
Compare BioNTech SE with similar companies based on industry and business-model similarity.
BioNTech SE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2025 | ||||
| Follow-on Offering | Jul 27, 2020 | ||||
| Debt | Jun 11, 2020 | ||||
| Debt | Dec 17, 2019 | ||||
| IPO | Oct 10, 2019 | ||||
Strategic | Aug 30, 2019 |
Key People
Founding team and executive leadership
BioNTech SE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B, Series A |
| Janus Henderson Group | Series B, Series A |
| Temasek | Debt |
| MIG Capital | Seed |
| UK government | Grant |
| Bryan, Garnier & Co. | Follow-on Offering, IPO |
| Canaccord Genuity | Follow-on Offering, IPO |
BioNTech SE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersMainz, Rhineland-Palatinate
Employee Range5,198
Year Founded2008
Last FundingMay 20, 2025